Back to top

SECOND AMENDMENT TO LIMITED LIABILITY COMPANY PURCHASE AGREEMENT

LLC Operating Agreement

SECOND AMENDMENT TO LIMITED LIABILITY COMPANY PURCHASE AGREEMENT | Document Parties: ADEONA PHARMACEUTICALS, INC. | Adeona Pharmaceuticals, Inc | Hart Lab LLC You are currently viewing:
This LLC Operating Agreement involves

ADEONA PHARMACEUTICALS, INC. | Adeona Pharmaceuticals, Inc | Hart Lab LLC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: SECOND AMENDMENT TO LIMITED LIABILITY COMPANY PURCHASE AGREEMENT
Governing Law: Illinois     Date: 7/16/2009
Industry: Biotechnology and Drugs     Sector: Healthcare

SECOND AMENDMENT TO LIMITED LIABILITY COMPANY PURCHASE AGREEMENT, Parties: adeona pharmaceuticals  inc. , adeona pharmaceuticals  inc , hart lab llc
50 of the Top 250 law firms use our Products every day

Exhibit 10.3

SECOND AMENDMENT TO

LIMITED LIABILITY COMPANY PURCHASE AGREEMENT

 

This second amendment (the “Second Amendment Agreement”) dated July 9 th   2009 to the Limited Liability Company Purchase Agreement (the “Purchase Agreement”) dated May 30, 2009 as amended by first amendment dated June 30, 2009, by and between Narayan Torke (“Seller”), Hart Lab LLC (the “Company”)  and Adeona Pharmaceuticals, Inc., (“Purchaser”). Purchaser, the Company and Seller may collectively be referred to as the “Parties.”

 

WHEREAS, on June 30, 2009 the parties entered into a first amendment to the Purchase Agreement dated May 30, 2009 to extend the closing date until July 10, 2009.

 

WHEREAS, the Parties desire to enter into this Second Amendment Agreement to amend certain provisions of the Purchase Agreement.

 

NOW, THEREFORE, in consideration for the promises set forth in this Agreement, the Parties agree as follows:

 

Sections 1, 2, 3, 4 and 9 of the Purchase Agreement are amended in their entirety to read as follows;

 

1.  

PURCHASE AND SALE:   Subject to the terms and conditions set forth in this Agreement, Purchaser hereby agrees to purchase from Seller, and Seller hereby agree to sell, transfer and convey to the Purchaser all of the interests of the Company, representing all of the issued and outstanding membership interests of the Company (the “Interests”).  The transaction shall also include the sale and transfer of the operating assets of the Company listed on Exhibit A. At closing (“Closing”) Purchaser shall transfer by wire $266,000.00 to an IOLTA bank account of Seller’s attorney pursuant to an Escrow Agreement under which a portion of such funds in the amount of $187,141.30 shall be paid to Seller as described herein this Agreement and the remainder of such funds in the amount of $78,858.70 shall either be released back to Purchaser upon (a) (i) evidence to the Seller’s attorney of the release of the personal guarantee of Seller under the Olympus and Baytree clinical equipment leases (the “Equipment Leases”), or (ii) evidence to Seller’s lawyer of payoff by Purchaser of the Equipment leases, or (b) released to Seller after 60 days in the event Seller is unable obtain the release of the personal guarantee of Seller or payoff the Equipment Leases within such 60 day period whereupon Seller shall become primarily obligated to pay the remaining $78,858.70 in lease expenses for the Olympus and Baytree clinical Equipment Leases over the remaining term of such leases with the Buyer to pay in full all other leases. Purchaser shall have the right to make employment offers to any or all of the Company’s existing employees after Closing. Purchaser shall become personally liable after Closing for the performance of all existing contracts that do not have change in control provisions, and for those that do, the Parties shall attempt to seek to negotiate such change in control authorization to continue such agreements in effect after Closing.  The Purchaser shall assume the existing real estate lease (the Real Estate Lease”) and seek and obtain the landlord’s consent to the change in ownership and use its best efforts to obtain a full release of Seller within 90 days of closing, or Purchaser shall indemnify Seller for all costs under the Real Estate Lease.  The Parties shall cooperate in good faith in the transfer of the CMS license and Illinois Dept. of Public Health license, including a power of attorney in favor of the Company following ownership transfer to the Purchaser until such licenses are transferred by CMS and Illinois.  A copy of  the power of attorney(s) are attached as Exhibit B.

 

2.  

PURCHASE PRICE:   The purchase price for all of the shares of Interests shall be Two Hundred and One Thousand One Hundred and Forty One dollars and Thirty cents ($201,141.30) in cash (the “Purchase Price”) with Fourteen Thousand dollars ($14,000) to be paid in cash to the Seller as a nonrefundable earnest payment creditable against the Purchase Price contemporaneous with the execution of this Agreement and the remainder of the Purchase Price of One Hundred Eighty Seven Thousand One Hundred Forty One dollars and Thirty cents  


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more